Status:
UNKNOWN
Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to see if a specialized imaging technique using MRI called multi-exponential T2 component analysis can reliably differentiate between normal brain and brain tumour.
Detailed Description
Existing methods of contouring tumours for radiation therapy involve manual interpretations of qualitative diagnostic images. These methods, being qualitative, do not offer a consistent and reproducib...
Eligibility Criteria
Inclusion
- Eighteen years of age or older
- Clinical subjects must have not yet begun radiation therapy
- Must have signed our study-specific consent form
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00813787
Start Date
February 1 2009
End Date
April 1 2015
Last Update
October 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2